Eric Chow & Co., in Association with Commerce & Finance Law Offices > Hong Kong, Hong Kong > Firm Profile

Eric Chow & Co., in Association with Commerce & Finance Law Offices
29/F, 238 Des Voeux Road Central
Sheung Wan, Hong Kong
Hong Kong

Hong Kong > PRC firms in Hong Kong Tier 2

With expertise spanning various sectors, including healthcare, real estate, telecoms, and automotive, the team at Eric Chow & Co., in Association with Commerce & Finance Law Offices has a successful track record in advising clients on a wide range of corporate finance matters, navigating issues such as private and public M&A transactions and IPO investments. The team continues to represent leading international and Chinese corporates and financial institutions, including CCB International and China Everbright. At the helm of this accomplished team is Eric Chow, a founding partner of the Hong Kong office who specialises in all facets of M&A, IPOs, joint ventures, and takeover transactions. Dual-qualified in Hong Kong and New York, Clement Jiang is a primary contact for clients in the healthcare, life sciences, and technology sectors. Another key figures within the team include Priscilla Lee, who focuses her practice on M&A and capital markets transactions. The arrival of Terence Lau from Norton Rose Fulbright in May 2023 has bolstered the firm’s corporate offering, as he brings expertise in ECMs, including Hong Kong IPOs, private M&A, and public takeovers.

Practice head(s):

Eric Chow

Other key lawyers:

Clement Jiang; Priscilla Lee; Brandon Chow; Winnie Tang; Jessie Cheung; Terence Lau; Christy Leung

Key clients

China Securities (International) Corporate Finance

Company Limited

China Merchants Securities (HK) Co., Limited

Fuli Gemstones International Holdings Limited

Beijing Luzhu Biotechnology Co., Ltd.

Firstar Holdings Group Limited

China XLX Fertiliser Ltd.

Alliance Capital Partners Limited

Concord Healthcare Group Co., Ltd

Aidigong Maternal & Child Health Limited

Work highlights

  • Advised Beijing Luzhu Biotechnology Co., Ltd. on its listing and global offering of H shares on the Main Board of the Hong Kong Stock Exchange.
  • Advised a Beijing State-owned Capital Operation and Management Company Limited on its acquisition of 22.35% equity interests in Shoucheng Holdings Limited.
  • Advised Concord Healthcare Group Co., Ltd. on its proposed listing on the Main Board of the Hong Kong Stock Exchange.

Hong Kong > Capital markets (equity) Tier 5

Under the leadership of Eric Chow, the ‘young, vibrant and knowledgeable’ team at Eric Chow & Co., in Association with Commerce & Finance Law Offices has gained significant traction among PRC issuers looking to raise equity on the HKEX, where it is appreciated for its ability to provide a ‘nimble, responsive and cost-effective service’. Priscilla Lee provides ‘pragmatic and very hands-on’ advice that is ‘attuned to client needs’ and is a key member of the team that was also strengthened on the sponsor side by the arrival in May 2023 of Terence Lau in a senior consultancy role from Norton Rose Fulbright.

Practice head(s):

Eric Chow

Other key lawyers:

Clement Jiang; Priscilla Lee; Terence Lau; Brandon Chow; Winnie Tang; Jessie Cheung

Testimonials

The team is young, vibrant and knowledgeable.’

‘It is a boutique size firm enabling them to provide quick advice and services to the client at a reasonable costs compared with city firms.’

‘Priscilla Lee is responsive, approachable, pragmatic and very hands-on.’

The diligent Priscilla Lee is particularly impressive and attuned to client needs.’

 

Key clients

China Securities (International) Corporate Finance Company Limited

China Merchants Securities (HK) Co., Limited

Fuli Gemstones International Holdings Limited

Beijing Luzhu Biotechnology Co., Ltd.

Firstar Holdings Group Limited

China XLX Fertiliser Ltd. (HKEx: 1866)

Alliance Capital Partners Limited

Concord Healthcare Group Co., Ltd

Aidigong Maternal & Child Health Limited

Work highlights

  • Advised Beijing Luzhu Biotechnology Co. in its listing and global offering of H shares on the Main Board of the Hong Kong Stock Exchange.
  • Advised Fuli Gemstones International Holdings Limited in its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited.
  • Advised Concord Healthcare Group Co., Ltd. in its proposed listing on the Main Board of the Hong Kong Stock Exchange.

Hong Kong > Corporate (including M&A)

Eric Chow & Co., in Association with Commerce & Finance Law Offices‘ ‘vibrant and knowledgeable’ team is well-placed to advise PRC clients on both inbound and outbound M&A mandates. Practice head and founding partner Eric Chow is noted for handling capital markets issues, regularly advising on IPOs in the healthcare, real estate, and TMT sectors. The ‘diligent’ and ‘impressive’ Priscilla Lee’s clientele typically consists of both PRC and Hong Kong companies, investment banks, and private equity funds; Lee has broad expertise in debt financing, direct investment, and regulatory issues concerning listed companies.

Practice head(s):

Eric Chow

Testimonials

‘Terence Lau is very professional, diligent, knowledgeable and responsive.’

‘The team is professional, reliable, and has commercial sense.’

‘Priscilla Lee in particular is impressive. She is diligent and knows what the client needs.’

‘The team is young, vibrant and knowledgeable.’

Key clients

Beijing State-owned Capital Operation and Management Company Limited

International Alliance Financial Leasing

Hubei Port (Hong Kong) International Limited

Cinese International Development Limited

Infinities Global Technology Limited Partnership

ZONQING Environmental Limited

Work highlights

  • Advised Beijing State-owned Capital Operation and Management Company Limited on its acquisition of 22.35% equity interests in Shoucheng Holdings Limited.
  • Advised International Alliance Financial Leasing on an acquisition of 70.00% of interests in Yantai Nanshan University, from Nanshan Holdings Co., Ltd. for a consideration of RMB 566 m.
  • Advised Chinese International Development Limited to acquire approximately 50.18% of the total issued share capital of Pinestone Capital Limited for HK$179.6 m.